https://liadwhatstein.com/ilpto-update-pte-eligibility-of-proteins/2023-07-11T13:14:40+03:00https://liadwhatstein.com/il-tm-update-new-legislation-to-encourage-parallel-importation/2023-07-11T13:08:58+03:00https://liadwhatstein.com/ilpto-update-another-il-pte-revoked-for-late-reporting-of-foreign-pte-spcs/2023-07-11T13:18:47+03:00https://liadwhatstein.com/iltmo-update-bad-faith-use-of-a-mark-can-lead-to-its-revocation/2023-07-11T14:11:56+03:00https://liadwhatstein.com/ilpto-update-patent-oppositions-no-longer-automatically-stayed/2023-07-11T15:26:28+03:00https://liadwhatstein.com/ilpto-update-intent-to-deceive-is-a-prerequisite-for-finding-of-fraud-on-the-pto/2023-07-11T15:43:43+03:00https://liadwhatstein.com/ilpto-update-second-medical-use-spcs-are-irrelevant-in-determining-the-term-of-il-ptes/2023-07-11T15:49:58+03:00https://liadwhatstein.com/il-tm-update-parallel-imports-not-permitted-in-cases-of-split-tm-ownership/2023-07-11T15:54:34+03:00https://liadwhatstein.com/ilpto-update-impact-of-cancellation-of-first-product-registration-on-validity-of-the-il-pte/2023-07-11T16:01:59+03:00https://liadwhatstein.com/ilpto-update-non-extendable-il-pte-deadlines/2023-07-11T16:13:44+03:00https://liadwhatstein.com/ilpto-update-ilpto-recognizes-strawman-oppositions/2023-07-11T16:17:26+03:00https://liadwhatstein.com/ilpto-update-the-deadline-for-filing-divisional-applications-cannot-be-extended/2023-07-11T16:38:08+03:00https://liadwhatstein.com/iltmo-update-new-instructions-on-cannabis-trademarks/2023-07-11T16:44:24+03:00https://liadwhatstein.com/il-tm-update-important-decision-on-non-use-and-recordal-of-trademark-licenses/2023-07-11T16:50:31+03:00https://liadwhatstein.com/il-biosimilar-update-new-moh-guidelines-facilitate-registration-of-biosimilars/2024-04-21T19:08:38+03:00https://liadwhatstein.com/israel-life-sciences-commercialization-and-life-sciences-regulation-qas-by-liad-whatstein-co/2023-07-25T19:52:32+03:00https://liadwhatstein.com/il-tm-update-court-holds-that-smell-a-likes-are-not-infringing/2023-10-16T20:54:20+03:00https://liadwhatstein.com/the-2023-legal-500-israel-patent-litigation-comparative-guide-by-liad-whatstein-co/2023-12-02T14:43:41+02:00https://liadwhatstein.com/the-2024-international-comparative-legal-guide-for-copyright-in-israel-by-liad-whatstein-co/2023-12-02T15:12:49+02:00https://liadwhatstein.com/il-patent-update-sanctions-for-misleading-representations-can-target-patentees-profits/2024-01-03T23:03:29+02:00https://liadwhatstein.com/ilpto-update-salt-patents-may-still-be-obtained-despite-another-restrictive-ilpto-decision/2024-01-31T10:34:23+02:00https://liadwhatstein.com/when-is-a-novel-protein-new-for-pte-purposes/2024-02-19T18:24:44+02:00https://liadwhatstein.com/ilpto-update-differences-in-glycosylation-profiles-may-be-sufficient-to-support-pte-eligibility-of-proteins/2024-04-04T22:10:50+03:00https://liadwhatstein.com/il-ministry-of-health-update-new-vip-super-fast-track-registration-for-generic-biosimilar-drugs/2024-04-21T19:07:58+03:00https://liadwhatstein.com/ilpto-update-broad-functional-antibody-claims-are-not-permissibleilpto-update/2024-07-17T15:51:50+03:00https://liadwhatstein.com/the-2024-legal-500-israel-patent-litigation-comparative-guide-by-liad-whatstein-co/2025-02-23T20:27:33+02:00https://liadwhatstein.com/the-2025-international-comparative-legal-guide-for-copyright-in-israel-by-liad-whatstein-co/2025-02-23T20:27:20+02:00https://liadwhatstein.com/il-pte-update-revocation-of-a-single-spc-in-the-european-recognized-countries-invalidates-the-il-pte/2025-03-18T20:35:14+02:00https://liadwhatstein.com/how-many-spcs-are-required-to-satisfy-the-il-pte-eligibility-requirement/2025-03-18T20:46:46+02:00https://liadwhatstein.com/tm-update-iltmo-reevaluates-and-expands-the-tests-for-determining-likelihood-of-confusion/2025-03-18T20:55:32+02:00https://liadwhatstein.com/new-moh-guidelines-to-expedite-approval-of-biosimilars-and-generics/2025-07-15T12:02:55+03:00https://liadwhatstein.com/a-new-bill-to-amend-the-patents-act-proposes-significant-revisions/2025-07-15T12:03:10+03:00https://liadwhatstein.com/a-comparative-study-illustrates-the-ilpto-stringent-homology-requirements-for-biological-sequences/2025-07-15T12:05:33+03:00https://liadwhatstein.com/streamlined-registration-of-medical-devices/2025-09-11T15:15:15+03:00https://liadwhatstein.com/will-il-case-law-align-with-the-epo-approach-to-second-medical-indication-patents/2025-10-08T16:13:05+03:00https://liadwhatstein.com/markman-hearings-in-opposition-and-revocation-proceedings-and-other-noteworthy-changes/2025-10-20T14:38:38+03:00https://liadwhatstein.com/legal-500-patent-litigation-comparative-guide-2025/2025-11-19T17:07:55+02:00https://liadwhatstein.com/israel-chapter-in-iclg-copyright-laws-2026/2025-11-19T17:33:16+02:00https://liadwhatstein.com/a-more-favourable-approach-to-patient-population-claims-by-the-ilpto/2026-01-12T18:11:21+02:00https://liadwhatstein.com/new-ilpto-commissioner-further-clarifies-the-patentability-thresholds-of-polymorphs/2026-02-09T15:23:04+02:00